Dana-Farber Cancer Institute - Tiff Trant recently joined a clinical trial testing an innovative treatment called CAR T-cell therapy, a form of...
Specialty: Hem/Onc (Journals, Associations and News Outlets)
Nature Reviews Cancer - This Review discusses how advances in our understanding of the immune system within the brain have implications for the successful implementation of immunotherapy to...
-
Back to the countdown! Our 5th most downloaded Review of 2020 (which technically was published end of 2019): Brain immunology and immunotherapy in brain tumours by John H. Sampson & colleagues @DukeNeurosurg https://t.co/oFAoYzLjtG https://t.co/oFAoYzLjtG
Memorial Sloan Kettering Cancer Center - MSK announces the establishment of The Tow Center for Developmental Oncology...
-
We're excited to announce The Tow Center for Developmental Oncology uniting scientists from across MSK to develop fundamental insights into cancers' molecular mechanisms in kids/young adults & devise new approaches for definitive therapy control. #MSKKids https://t.co/o9X79X5Uf1
OncLive - In our exclusive interview, Toni K. Choueiri, MD, provides perspective on the FDA approval of nivolumab and cabozantinib in advanced renal cell...
-
LISTEN: In our exclusive interview, @DrChoueiri provides perspective on the FDA approval of nivolumab and cabozantinib in advanced renal cell carcinoma #kcsm https://t.co/2u4EbaxJkK https://t.co/2u4EbaxJkK
cancerdiscovery.aacrjournals.org - A Decade of Discoveries in Cancer Discovery. For the Community. By the Community. Research Research Community Featured Editors-in Chief: Lewis C. Cantley,...
-
We’re excited about the 10th anniversary of Cancer Discovery. Join the celebration as we recognize authors and editors for their contributions to the success of the journal over the last decade. @AACR #CDturns10 https://t.co/BxII8pcy4z https://t.co/BxII8pcy4z
Periscope - NIH was...
-
Here's the video of the #NIH vaccination event that just happened with @NIHDirector @VP Kamala Harris https://t.co/pekcNilxDA @moderna_tx #SleeveUp #MyCOVIDVaccine
Nature - Cell-line screens create expansive datasets for learning predictive markers of drug response, but these models do not readily translate to the clinic with its...
-
⚡️ONLINE NOW @NatureCancer: "Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients" by @TreyIdeker Don't miss it! https://t.co/aZ44lQZIAZ https://t.co/aZ44lQZIAZ https://t.co/aZ44lQZIAZ
academic.oup.com - We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we...
-
Using patient reported outcomes to describe the patient experience on phase I cancer clinical trials. @ramsedhom @hopkinskimmel https://t.co/IDpZKG1rMF https://t.co/IDpZKG1rMF
VJOncology - End-of-year wrap-up presenting the biggest findings and changes to clinical practice that have happened during...
-
The @OncoAlert Colloquium provided a fantastic forum for oncologists to discuss the best of 2020. Watch on-demand now: 👉https://t.co/qC5Fm1YkER👈 #OncoAlert @VJOncology #GUsm #BLCsm #PCsm #KCsm #LCsm #BCsm #LYMsm #CRCsm #GIsm https://t.co/qC5Fm1YkER👈
Adekunle Odunsi named director of UChicago Medicine Comprehensive Cancer Center – The Cancer Letter
posted 7 hours
Mashup Score: 4
Cancer Letter - publication date: Jan. 22, 2021In BriefAdekunle “Kunle” Odunsi, an expert in immunotherapy and vaccine therapy for cancer, was named director of the University of...
-
Adekunle “Kunle” Odunsi (@KunleOdunsiMD), an expert in immunotherapy and vaccine therapy for cancer, was named director of the University of Chicago Medicine Comprehensive Cancer Center (@UCCancerCenter) effective March 1. @UChicagoMed https://t.co/WmMxGpw04S https://t.co/WmMxGpw04S
Tiffany "Tiff" Trant recently joined a clinical trial testing an innovative treatment called CAR T-cell therapy. Today, she is in remission, & enjoying every second. “I’m not waiting for the big moments, but rather enjoying the little moments every day.” https://t.co/eWtuxOR000